New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 22, 2014
08:06 EDTEPZMEpizyme receives $4M milestone and license payment
Epizyme announced the achievement of the lead candidate milestone for the third of the three histone methyltransferase targets in the company's collaboration with GSK and is receiving $4M in milestone and license payments. Previously, Epizyme announced the achievement of a $4M development candidate milestone for the first GSK collaboration target in January and a $2M lead candidate selection milestone for the second GSK collaboration target in February.
News For EPZM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 25, 2015
07:41 EDTEPZMEpizyme management to meet with Leerink
Subscribe for More Information
June 22, 2015
13:20 EDTEPZMOn The Fly: Top stock stories at midday
Subscribe for More Information
June 21, 2015
15:09 EDTEPZMEpizyme to hold a conference call
Subscribe for More Information
12:37 EDTEPZMEpizyme reports phase 1 tazemetostat results, plans phase 2 trial in Q2
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use